Medasense
Medasense

Medasense

DR32Ahrefs DR: 32/100. Below median. Measured by Ahrefs. Median 44.Agent50Agent Readiness: 50/100. Top 25%. Measured by StartupHub.ai. Median 41.Speed29Site Speed: 29/100. Bottom 25%. Measured by Google PageSpeed. Median 62.

Medasense quantifies pain response using breakthrough NOL® AI technology to optimize patient care and avoid overmedication.

Website
2008Inactive26Tel Aviv, Israel

About

Medasense is transforming pain assessment and treatment globally. Their breakthrough NOL® AI technology and sensing platform objectively quantify pain response, enabling clinicians to optimize care and prevent overmedication. The flagship product, PMD-200™, is utilized in critical care settings.

Competitors & alternatives (6)

Key facts

At-a-glance profile data

Website
medasense.com
Headquarters
Tel Aviv, Israel
Founded
2008
Employees
26
Total funding
$40M (Series C)
Business model
B2B

Funding rounds

Funding rounds raised by Medasense
DateRoundAmountLead investors
22 Sept 2020Series C$18M-
12 Sept 2018Series B$12M-
29 Feb 2016Series B$8M-
30 Nov 2010Series A$1M-
30 Nov 2008SeedUndisclosed-

Tech stack

Detected on medasense.com, last scanned 1 Jul 2026.

Hosting
Google Cloud
Email provider
Microsoft 365
Run your own scan
Add first review

Frequently asked

How much funding has Medasense raised?

Medasense has raised a total of $40M in funding. The most recent round on record is Series C.

How many employees does Medasense have?

Medasense has approximately 26 people on record.

What is Medasense's current status?

Medasense's current operating status is: Inactive.